The Soviet Union's invisible weapons of mass destruction : Biopreparat's covert biological warfare programme
著者
書誌事項
The Soviet Union's invisible weapons of mass destruction : Biopreparat's covert biological warfare programme
Palgrave Macmillan, c2021
- : hbk
大学図書館所蔵 件 / 全1件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
内容説明
This book focuses on Biopreparat, the Soviet agency created in 1974, which spearheaded the largest and most sophisticated biological warfare programme the world has ever seen. At its height, Biopreparat employed more than 30,000 personnel and incorporated an enormous network embracing military-focused research institutes, design centres, biowarfare pilot facilities and dual-use production plants. The secret network pursued major offensive R&D programmes, which sought to use genetic engineering techniques to create microbial strains resistant to antibiotics and with wholly new and unexpected pathogenic properties. During the mid-1980s, Biopreparat increased in size and political importance and also emerged as a major civil biopharmaceutical player in the USSR. In the wake of the collapse of the Soviet Union in 1991, an acute struggle for control of Biopreparat's most valuable assets took place and the network was eventually broken-up and control of its facilities transferred to a myriad of state agencies and private companies.
目次
Chapter 1: Introduction.- Chapter 2: The Secret History: Khrushchev's Creation of Soviet Reserve Biological Warfare Mobilization Facilities within Civil Production Plants in the 1950s and 1960s.- Chapter 3: Glavmikrobioprom and the Emergence of the Soviet Microbiological Industry.- Chapter 4: Genesis: The Creation of Biopreparat.- Chapter 5: Anthrax on the Kazakh Steppe: Biopreparat's Network of Experimental-Industrial Bases.- Chapter 6: The Creation of Biopreparat's Scientific Base: The R&D Complexes at Obolensk, Kol'tsovo and Leningrad.- Chapter 7: A Roadmap to the Future? The Emergence of Biopreparat as a Major Civil Biopharmaceutical Player.- Chapter 8: A Brave New World: Building Capitalism in the New Russia and the Struggle for Control of Biopreparat.- Chapter 9: Conclusion.
「Nielsen BookData」 より
